Deep Track Capital, LP 13D/13G Filings for Heron Therapeutics, Inc. (HRTX)

Deep Track Capital, LP 13D and 13G filings for Heron Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-14
08:46 am
Sale		 2023-12-31 13G Heron Therapeutics, Inc.
HRTX		 Deep Track Capital, LP 0
0.000%		 -12,232,267decrease
(Position Closed)		 Filing
2022-08-19
4:03 pm
Purchase		 2022-08-09 13G Heron Therapeutics, Inc.
HRTX		 Deep Track Capital, LP 12,232,267
9.990%		 12,232,267increase
(New Position)		 Filing